title: First-in-class HIV drug enters phase 3 trials.
authors.forename: Anna
authors.initials: A
authors.lastname: Azvolinsky
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects / Q000472:pathogenicity; D006801:Humans; D010755:Organophosphates / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D010755:Organophosphates; D010879:Piperazines; C576364:fostemsavir